4.7 Article

Novel 3,5-Bis(bromohydroxybenzylidene)piperidin-4-ones as Coactivator-Associated Arginine Methyltransferase 1 Inhibitors: Enzyme Selectivity and Cellular Activity

期刊

JOURNAL OF MEDICINAL CHEMISTRY
卷 54, 期 13, 页码 4928-4932

出版社

AMER CHEMICAL SOC
DOI: 10.1021/jm200453n

关键词

-

资金

  1. Fondazione Roma
  2. COST Action Epigenetics [TD09/05]
  3. NIEHS [ES007784, ES015188]

向作者/读者索取更多资源

Coactivator-associated arginine methyltransferase 1 (CARM1) represents a valuable target for hormone-dependent tumors such as prostate and breast cancers. Here we report the enzyme and cellular characterization of the 1-benzyl-3,5-bis(3-bromo-4-hydroxybenzylidene)piperidin-4-one (7g) and its analogues 8a-1. Among them, 7g, 8e, and 8a-1 displayed high and selective CARM1 inhibition, with lower or no activity against a panel of different PRMTs or HKMTs. In human LNCaP cells, 7g showed a significant dose-dependent reduction of the PSA promoter activity.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Chemistry, Medicinal

Chemically Diverse S. mansoni HDAC8 Inhibitors Reduce Viability in Worm Larval and Adult Stages

Beatrice Noce, Elisabetta Di Bello, Clemens Zwergel, Rossella Fioravanti, Sergio Valente, Dante Rotili, Andrea Masotti, Mohammad Salik Zeya Ansari, Daniela Trisciuoglio, Alokta Chakrabarti, Christophe Romier, Dina Robaa, Wolfgang Sippl, Manfred Jung, Cecile Haeberli, Jennifer Keiser, Antonello Mai

Summary: Schistosoma mansoni HDAC8 is a reliable target for combating schistosomiasis, but most inhibitors lack selectivity over human deacetylases and have low or no activity against the parasite. In this study, a small library of HDAC inhibitors from the lab was tested for their in vitro enzyme and biological activity. These inhibitors showed submicromolar/nanomolar potency against smHDAC8 and varied selectivity over hHDAC1 and/or hHDAC6. Some compounds exhibited high activity against larval and adult stages of S. mansoni with moderate to no toxicity in human fibroblast cells.

CHEMMEDCHEM (2023)

Review Biochemistry & Molecular Biology

EFMC: Trends in Medicinal Chemistry and Chemical Biology

Yves P. P. Auberson, Paola B. B. Arimondo, Maria Duca, Sebastian Essig, Uwe Grether, Arne C. C. Rufer, Gianluca Sbardella, Ulrich Schopfer, Antoni Torrens, Mario van Der Stelt, Boris Vauzeilles, Olalla Vazquez, Andrew D. X. Zhang

Summary: Ground-breaking research and method development in disease biology have led to the discovery of potential new drug targets. Chemical probes are increasingly being used in the drug discovery process, for target identification and assessment, as well as qualifying small molecules as drug candidates. The progress in probe chemistry has led to the development of novel assay formats and pharmaceutical compound classes. EFMC has launched the Chemical Biology Initiative to advance science in medicinal chemistry and chemical biology and represent the scientific community.

CHEMBIOCHEM (2023)

Article Chemistry, Medicinal

Novel pyridine-containing histone deacetylase inhibitors strongly arrest proliferation, induce apoptosis and modulate miRNAs in cancer cells

Elisabetta Di Bello, Veronica Sian, Giulio Bontempi, Clemens Zwergel, Rossella Fioravanti, Beatrice Noce, Carola Castiello, Stefano Tomassi, Davide Corinti, Daniela Passeri, Roberto Pellicciari, Ciro Mercurio, Mario Varasi, Lucia Altucci, Marco Tripodi, Raffaele Strippoli, Angela Nebbioso, Sergio Valente, Antonello Mai

Summary: After years of research, HDAC inhibitors have been developed and approved by FDA/Chinese FDA for the treatment of cancer and non-cancer diseases. A series of novel compounds have been discovered to be effective anticancer agents, demonstrating selective inhibition of HDACs and inducing cell death and differentiation. These compounds also modulate gene and protein expression related to apoptosis and show potent antiproliferative activity in various cancer cell lines.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Chemistry, Medicinal

METTL3 from Target Validation to the First Small-Molecule Inhibitors: A Medicinal Chemistry Journey

Francesco Fiorentino, Martina Menna, Dante Rotili, Sergio Valente, Antonello Mai

Summary: RNA methylation is a crucial mechanism for regulating gene expression and RNA maturation. METTL3, an RNA methyltransferase, plays a key role in this process by adding a methyl group to N6-adenosine of RNA. Dysregulation of METTL3 can lead to various diseases and viral infections. By studying the correlation between METTL3 and diseases, as well as analyzing the development and mode of action of known METTL3 inhibitors, we can gain a better understanding of the biological functions of this enzyme and potentially develop new therapeutics.

JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Biochemistry & Molecular Biology

Comparative Study of Adenosine Analogs as Inhibitors of Protein Arginine Methyltransferases and a Clostridioides difficile-Specific DNA Adenine Methyltransferase

Jujun Zhou, Youchao Deng, Iredia D. Iyamu, John R. Horton, Dan Yu, Taraneh Hajian, Masoud Vedadi, Dante Rotili, Antonello Mai, Robert M. Blumenthal, Xing Zhang, Rong Huang, Xiaodong Cheng

Summary: We modified S-adenosyl-L-methionine (SAM) analogs to discover potent and selective inhibitors of Clostridioides difficile-specific DNA adenine MTase (CamA). Compound 11a, with a 3-phenylpropyl moiety at the adenine N6-amino group and a 3-(cyclohexylmethyl guanidine)-ethyl moiety at the sulfur atom, exhibited higher inhibitory activity against CamA compared to its parental compounds. Our study provides a hybrid approach for generating CamA inhibitors and offers potential chemical agents to investigate the mechanism and therapeutic potential of CamA in C. difficile infection.

ACS CHEMICAL BIOLOGY (2023)

Article Chemistry, Medicinal

The European Federation for Medicinal Chemistry and Chemical Biology (EFMC) Best Practice Initiative: Hit Generation

Jean Quancard, Anna Vulpetti, Anders Bach, Brian Cox, Stephanie M. Gueret, Ingo V. Hartung, Hannes F. Koolman, Stefan Laufer, Josef Messinger, Gianluca Sbardella, Russell Craft

Summary: Hit generation is a crucial step in drug discovery that determines the speed and success rate of identifying drug candidates. Different strategies are available for identifying chemical starting points for each biological target. This article discusses the best practices for target-centric hit generation, validation of hits, and the design of integrated strategies to maximize the chance of identifying high-quality starting points.

CHEMMEDCHEM (2023)

Article Biochemistry & Molecular Biology

Antihistamines, phenothiazine-based antipsychotics, and tricyclic antidepressants potently activate pharmacologically relevant human carbonic anhydrase isoforms II and VII

Francesco Fiorentino, Alessio Nocentini, Dante Rotili, Claudiu T. Supuran, Antonello Mai

Summary: Carbonic anhydrases (CAs) are important regulators of pH homeostasis and participate in many physiological and pathological processes. This study investigated various drugs as potential CA activators and found that phenothiazine-based antipsychotics and tricyclic antidepressants were the most effective at activating hCA VII. These findings provide insights into the pharmacological profiles of clinically employed drugs and may contribute to the development of novel CA activators.

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2023)

Article Chemistry, Medicinal

First-in-Class Selective Inhibitors of the Lysine Acetyltransferase KAT8

Francesco Fiorentino, Sara Sementilli, Martina Menna, Federica Turrisi, Stefano Tomassi, Francesca Romana Pellegrini, Angela Iuzzolino, Francesca D'Acunzo, Alessandra Feoli, Hannah Wapenaar, Sophie Taraglio, Caterina Fraschetti, Donatella Del Bufalo, Gianluca Sbardella, Frank J. Dekker, Alessandro Paiardini, Daniela Trisciuoglio, Antonello Mai, Dante Rotili

Summary: KAT8, a lysine acetyltransferase, is involved in the development and metastasis of various cancer types. Two newly developed compounds, 19 and 34, are selective KAT8 inhibitors with low-micromolar activity and show antiproliferative effects in cancer cell lines, while not affecting nontransformed cells. These compounds provide valuable tools for studying KAT8 biology and have potential for further optimization studies.

JOURNAL OF MEDICINAL CHEMISTRY (2023)

Review Cell Biology

Emerging Roles of SIRT5 in Metabolism, Cancer, and SARS-CoV-2 Infection

Emanuele Fabbrizi, Francesco Fiorentino, Vincenzo Carafa, Lucia Altucci, Antonello Mai, Dante Rotili

Summary: SIRT5, a mitochondrial enzyme, regulates cellular homeostasis and the activity of proteins involved in various metabolic pathways. It plays critical roles in myocardial energy metabolism, neurodegenerative disease protection, and tumor development. SIRT5 is also implicated in SARS-CoV-2 infection. This review discusses its molecular actions, effects on metabolic targets, potential as a therapeutic target, and currently reported modulators including activators and inhibitors.
Article Biochemistry & Molecular Biology

The role of structural biology in the design of sirtuin activators

Francesco Fiorentino, Antonello Mai, Dante Rotili

Summary: Sirtuins are NAD+-dependent enzymes with multiple functions, including DNA repair, cell survival, metabolism, ROS detoxification, inflammation, cardiac function, and neuronal signaling. The development of sirtuin activators has gained significant interest due to their beneficial effects on health and lifespan. Structural biology has played a crucial role in discovering and characterizing these activators, providing insights into their mechanisms of action and enabling the design of more potent and selective molecules.

CURRENT OPINION IN STRUCTURAL BIOLOGY (2023)

Editorial Material Chemistry, Medicinal

State of the art of carbonic anhydrase activators

Francesco Fiorentino, Fabrizio Carta, Dante Rotili, Antonello Mai, Claudiu T. Supuran

FUTURE MEDICINAL CHEMISTRY (2023)

Article Chemistry, Medicinal

Identification of a Protein Arginine Methyltransferase 7 (PRMT7)/Protein Arginine Methyltransferase 9 (PRMT9) Inhibitor

Alessandra Feoli, Giulia Iannelli, Alessandra Cipriano, Ciro Milite, Lei Shen, Zhihao Wang, Andrea Hadjikyriacou, Troy L. Lowe, Cyrus Safaeipour, Monica Viviano, Giuliana Sarno, Elva Morretta, Maria Chiara Monti, Yanzhong Yang, Steven G. Clarke, Sandro Cosconati, Sabrina Castellano, Gianluca Sbardella

Summary: PRMT7 and PRMT9 have been identified as important therapeutic targets, but their biological roles, functions, and structural requirements are still unclear. This study discovered a potent PRMT7/9 inhibitor and revealed its binding mode to the two enzymes. The inhibition of PRMT activity in cells was confirmed, and an effective AlphaLISA assay was developed for screening small molecule inhibitors of PRMT9.

JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Chemistry, Medicinal

NADPH Oxidases: From Molecular Mechanisms to Current Inhibitors

Alessandra Cipriano, Monica Viviano, Alessandra Feoli, Ciro Milite, Giuliana Sarno, Sabrina Castellano, Gianluca Sbardella

Summary: NADPH oxidases (NOXs) are electron transporting membrane enzymes that generate reactive oxygen species (ROS). Selective NOX inhibitors have not yet been identified, making it challenging to use them as therapeutic targets in vivo. This Perspective provides an updated overview of small-molecule NOX inhibitors described in the last two decades, discussing their structures, activities, specificity, and the main biological assays used.

JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Biochemistry & Molecular Biology

Targeting ROS production through inhibition of NADPH oxidases

Joana Reis, Christoph Gorgulla, Marta Massari, Sara Marchese, Sergio Valente, Beatrice Noce, Lorenzo Basile, Ricarda Toerner, Huel Cox, Thibault Viennet, Moon Hee Yang, Melissa M. Ronan, Matthew G. Rees, Jennifer A. Roth, Lucia Capasso, Angela Nebbioso, Lucia Altucci, Antonello Mai, Haribabu Arthanari, Andrea Mattevi

Summary: In this study, the authors validate inhibitors for human NOX enzymes using computational and experimental methods, opening avenues for cancer drug development and research in redox biology.

NATURE CHEMICAL BIOLOGY (2023)

Article Biochemistry & Molecular Biology

SIRT5 Activation and Inorganic Phosphate Binding Reduce Cancer Cell Vitality by Modulating Autophagy/Mitophagy and ROS

Federica Barreca, Michele Aventaggiato, Laura Vitiello, Luigi Sansone, Matteo Antonio Russo, Antonello Mai, Sergio Valente, Marco Tafani

Summary: This study suggests that activation of SIRT5 and reduction in Pi could be a valid strategy to inhibit cell proliferation by reducing glutamine metabolism and mitophagy, leading to the accumulation of ROS.

ANTIOXIDANTS (2023)

暂无数据